Market revenue in 2022 | USD 1,316.3 million |
Market revenue in 2030 | USD 2,004.1 million |
Growth rate | 5.4% (CAGR from 2022 to 2030) |
Largest segment | Drug discovery |
Fastest growing segment | Nanorobotics for Drug Delivery |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Nanorobotics for Drug Delivery, Regenerative Medicine, Diagnostic and Biological, Bioelectronics, Engineered Living Materials, Optogenetics, Precision Medicine |
Key market players worldwide | BiomX Inc, Ginkgo Bioworks Holdings Inc, SetPoint Medical, GSK PLC, BICO |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare bioconvergence market will help companies and investors design strategic landscapes.
Drug discovery was the largest segment with a revenue share of 18.96% in 2022. Horizon Databook has segmented the South Africa healthcare bioconvergence market based on drug discovery, nanorobotics for drug delivery, regenerative medicine, diagnostic and biological, bioelectronics, engineered living materials, optogenetics, precision medicine covering the revenue growth of each sub-segment from 2017 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa healthcare bioconvergence market, including forecasts for subscribers. This country databook contains high-level insights into South Africa healthcare bioconvergence market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account